The endocannabinoid system and its therapeutic exploitation VD Marzo, M Bifulco, LD Petrocellis Nature reviews Drug discovery 3 (9), 771-784, 2004 | 1484 | 2004 |
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide T Bisogno, L Hanuš, L De Petrocellis, S Tchilibon, DE Ponde, I Brandi, ... British journal of pharmacology 134 (4), 845-852, 2001 | 1380 | 2001 |
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors SM Huang, T Bisogno, M Trevisani, A Al-Hayani, L De Petrocellis, F Fezza, ... Proceedings of the National Academy of Sciences 99 (12), 8400-8405, 2002 | 1229 | 2002 |
Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes L De Petrocellis, A Ligresti, AS Moriello, M Allarà, T Bisogno, S Petrosino, ... British journal of pharmacology 163 (7), 1479-1494, 2011 | 1069 | 2011 |
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action V Di Marzo, D Melck, T Bisogno, L De Petrocellis Trends in neurosciences 21 (12), 521-528, 1998 | 1004 | 1998 |
Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia I Matias, MP Gonthier, P Orlando, V Martiadis, L De Petrocellis, C Cervino, ... The Journal of Clinical Endocrinology & Metabolism 91 (8), 3171-3180, 2006 | 774 | 2006 |
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity S Ben-Shabat, E Fride, T Sheskin, T Tamiri, MH Rhee, Z Vogel, T Bisogno, ... European journal of pharmacology 353 (1), 23-31, 1998 | 772 | 1998 |
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma A Ligresti, AS Moriello, K Starowicz, I Matias, S Pisanti, L De Petrocellis, ... Journal of Pharmacology and Experimental Therapeutics 318 (3), 1375-1387, 2006 | 727 | 2006 |
The endocannabinoid system: a general view and latest additions LD Petrocellis, MG Cascio, VD Marzo British journal of pharmacology 141 (5), 765-774, 2004 | 663 | 2004 |
Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain L Cristino, L De Petrocellis, G Pryce, D Baker, V Guglielmotti, V Di Marzo Neuroscience 139 (4), 1405-1415, 2006 | 571 | 2006 |
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation L De Petrocellis, D Melck, A Palmisano, T Bisogno, C Laezza, M Bifulco, ... Proceedings of the National Academy of Sciences 95 (14), 8375-8380, 1998 | 551 | 1998 |
N-acyl-dopamines: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo T Bisogno, D Melck, MY Bobrov, NM Gretskaya, VV Bezuglov, ... Biochemical Journal 351 (3), 817-824, 2000 | 502 | 2000 |
From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology A Ligresti, L De Petrocellis, V Di Marzo Physiological reviews, 2016 | 471 | 2016 |
Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes T Bisogno, S Maurelli, D Melck, L De Petrocellis, V Di Marzo Journal of Biological Chemistry 272 (6), 3315-3323, 1997 | 443 | 1997 |
N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia CJ Chu, SM Huang, L De Petrocellis, T Bisogno, SA Ewing, JD Miller, ... Journal of Biological Chemistry 278 (16), 13633-13639, 2003 | 432 | 2003 |
Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like … L De Petrocellis, T Bisogno, JB Davis, RG Pertwee, V Di Marzo FEBS letters 483 (1), 52-56, 2000 | 422 | 2000 |
The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism L De Petrocellis, T Bisogno, M Maccarrone, JB Davis, A Finazzi-Agro, ... Journal of Biological Chemistry 276 (16), 12856-12863, 2001 | 414 | 2001 |
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8 L De Petrocellis, V Vellani, A Schiano-Moriello, P Marini, PC Magherini, ... Journal of Pharmacology and Experimental Therapeutics 325 (3), 1007-1015, 2008 | 398 | 2008 |
Why do cannabinoid receptors have more than one endogenous ligand? V Di Marzo, L De Petrocellis Philosophical Transactions of the Royal Society B: Biological Sciences 367 …, 2012 | 381 | 2012 |
Biosynthesis and inactivation of the endocannabinoid 2‐arachidonoylglycerol in circulating and tumoral macrophages V Di Marzo, T Bisogno, L De Petrocellis, D Melck, P Orlando, JA Wagner, ... European Journal of Biochemistry 264 (1), 258-267, 1999 | 357 | 1999 |